✦ LIBER ✦

Cisplatin, etoposide, and ifosfamide in non-small cell lung carcinoma. A phase II randomized study with cisplatin and etoposide as the control arm

Book ID: 123211147
Publisher: Elsevier Science
Year: 1991
Tongue: English
Weight: 159 KB
Volume: 7
Category: Article
ISSN: 0169-5002
DOI: 10.1016/0169-5002(91)90217-T

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cisplatin, etoposide, and ifosfamide in

✍ Adriano Paccagnella; Adolfo Favaretto; Alba Brandes; Cristina Ghiotto; Driano Fo 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 434 KB 👁 2 views

Pilot study with cisplatin, ifosfamide,

Pilot study with cisplatin, ifosfamide, and etoposide in advanced non-small-cell lung carcinoma

📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 327 KB

Ifosfamide, cisplatin and etoposide in a

Ifosfamide, cisplatin and etoposide in advanced non small cell lung cancer

✍ Camps, C; Berrocal, A.; Vicent, J.M.; Godes, M. 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 166 KB

A prospective randomized phase III study

A prospective randomized phase III study in non-small-cell lung cancer comparing cisplatin, ifosfamide, vinbiastine (VIP) versus cisplatin, ifosfamide and etoposide (VIP-16)

📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 132 KB

Ifosfamide, cisplatin and etoposide comb

Ifosfamide, cisplatin and etoposide combination in locally advanced inoperable non-small-cell lung cancer: a phase II study

✍ Scinto, A F; Ferraresi, V; Milella, M; Tucci, E; Santomaggio, C; Pasquali-Lasagn 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 77 KB

Cisplatin/ifosfamide/vinblastine (VIP) v

Cisplatin/ifosfamide/vinblastine (VIP) vs, cisplatin/ifosfamide etoposide (VIR-16) in non-small cell lung cancer (NSCLC). A prospective randomized phase III study

✍ Kosmidis, P.; Mylonakis, N.; Fountzilas, G.; Pavlidis, N.; Samantas, E.; Karabel 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 140 KB